HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Bronchial allergen provocation: a useful method to assess the efficacy of specific immunotherapy in children.

AbstractBACKGROUND:
The clinical efficacy of subcutaneous allergen-specific immunotherapy (SCIT) varies between patients. New preparations are under development, and an objective tool with which to evaluate their efficacies in individual patients has become necessary. Our primary research question is whether bronchial allergen provocation (BAP) can be used to assess the efficacy of SCIT.
METHODS:
In 42 house dust mite (HDM) allergic children (average age: 8.6 yr) with asthma, we analysed the clinical and objective improvements of a standardised HDM allergoid. All patients underwent two BAPs, one before SCIT and another 1 yr after SCIT. Fourteen patients who were recommended but chose not to undergo SCIT represented the control group. The total and specific IgE were analysed before SCIT; in addition, after SCIT, specific IgG and IgG4 were analysed.
RESULTS:
After SCIT, the patients' allergen-specific bronchial hyper-reactivity (BHR) was significantly improved; specifically, their PD(20) FEV(1) was 34.4 AU before and 63.3 AU after SCIT (p < 0.01). The PD(20) FEV(1) of the control group remained unchanged. Although BHR improved significantly in the treatment group, we were able to differentiate between the responders (n = 17, 60.7%) and non-responders (n = 11, no improvement in BAP). The patients in both groups stated that SCIT had led to a subjective improvement in their symptoms, in contrast to the untreated control group, but only the responders required less medication after SCIT (p < 0.01).
CONCLUSIONS:
After 1 yr of SCIT against HDM, 60.7% of the patients observed in this study exhibited significant improvements, as defined by BAP. However, BAP was also able to identify the non-responders to treatment. Thus, BAP is a useful and objective method of estimating the effectiveness of SCIT and is not influenced by a placebo effect.
AuthorsMartin Rosewich, Sonja Arendt, Samir El Moussaoui, Johannes Schulze, Ralf Schubert, Stefan Zielen
JournalPediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology (Pediatr Allergy Immunol) Vol. 24 Issue 5 Pg. 434-40 (Aug 2013) ISSN: 1399-3038 [Electronic] England
PMID23578317 (Publication Type: Journal Article)
Copyright© 2013 John Wiley & Sons A/S. Published by Blackwell Publishing Ltd.
Chemical References
  • Antigens, Dermatophagoides
  • Immunoglobulin E
Topics
  • Adolescent
  • Animals
  • Antigens, Dermatophagoides (administration & dosage, immunology)
  • Asthma (diagnosis, immunology, therapy)
  • Bronchial Provocation Tests (methods)
  • Child
  • Child, Preschool
  • Desensitization, Immunologic (methods)
  • Female
  • Humans
  • Immunoglobulin E (blood)
  • Male
  • Pyroglyphidae (immunology)
  • Respiratory Function Tests

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: